These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28575813)

  • 1. A novel prognostic indicator for in-hospital and 4-year outcomes in patients with pulmonary embolism: TIMI risk index.
    Keskin M; Güvenç TS; Hayıroğlu Mİ; Kaya A; Tatlısu MA; Avşar Ş; Öz A; Keskin T; Uzun AO; Kozan Ö
    J Crit Care; 2017 Oct; 41():183-190. PubMed ID: 28575813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIMI Risk Index as a Predictor of 30-Day Outcomes in Patients With Acute Pulmonary Embolism.
    Zuin M; Conte L; Picariello C; Pastore G; Vassiliev D; Lanza D; Zonzin P; Zuliani G; Rigatelli G; Roncon L
    Heart Lung Circ; 2018 Feb; 27(2):190-198. PubMed ID: 28487060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive role of modified TIMI risk index in patients with ST-segment elevation myocardial infarction.
    Kaya A; Keskin M; Güvenç TS; Tatlısu MA; Kayapınar O
    Acta Cardiol; 2019 Feb; 74(1):29-36. PubMed ID: 29475415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Admission Glucose Level Predicts In-hospital Mortality in Patients with Acute Pulmonary Embolism Who Were Treated with Thrombolytic Therapy.
    Bozbay M; Uyarel H; Avsar S; Oz A; Keskin M; Murat A; Kaya A; Atas H; Cincin AA; Ugur M; Eren M
    Lung; 2016 Apr; 194(2):219-26. PubMed ID: 26896039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial.
    Truong QA; Cannon CP; Zakai NA; Rogers IS; Giugliano RP; Wiviott SD; McCabe CH; Morrow DA; Braunwald E
    Am Heart J; 2009 Apr; 157(4):673-9.e1. PubMed ID: 19332194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
    J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for intracranial haemorrhage in patients with pulmonary embolism treated with thrombolytic therapy Development of the PE-CH Score.
    Chatterjee S; Weinberg I; Yeh RW; Chakraborty A; Sardar P; Weinberg MD; Kabrhel C; Barnes GD; Mukherjee D; Kumbhani D; Bashir R; Vaidya A; Smith A; Fuchs B; Groeneveld P; Giri J
    Thromb Haemost; 2017 Jan; 117(2):246-251. PubMed ID: 27882375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIMI risk score for acute myocardial infarction according to prognostic stratification.
    Pereira JL; Sakae TM; Machado MC; Castro CM
    Arq Bras Cardiol; 2009 Aug; 93(2):105-12. PubMed ID: 19838486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction.
    Wiviott SD; Morrow DA; Frederick PD; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2006 Apr; 47(8):1553-8. PubMed ID: 16630990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice patterns and complication rates of thrombolysis for pulmonary embolism.
    Bradford MA; Lindenauer PK; Walkey AJ
    J Thromb Thrombolysis; 2016 Oct; 42(3):313-21. PubMed ID: 26961258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effecting factors on survival in patients taking thrombolytic treatment due to massive pulmonary embolism].
    Hatipoğlu ON; Perinçek G; Cakır Edis E; Tabakoğlu E; Altıay G
    Tuberk Toraks; 2010; 58(3):268-77. PubMed ID: 21038137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive prognostic value of left ventricular ejection fraction to the TIMI risk score for in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction.
    Wei XB; Liu YH; He PC; Jiang L; Zhou YL; Chen JY; Tan N; Yu DQ
    J Thromb Thrombolysis; 2017 Jan; 43(1):1-6. PubMed ID: 27501999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-to-lymphocyte ratio as a novel marker of in-hospital and long-term adverse outcomes among patients with acute pulmonary embolism: A single center large-scale study.
    Ozcan Cetin EH; Cetin MS; Canpolat U; Akdi A; Aras D; Temizhan A; Aydogdu S
    Thromb Res; 2017 Feb; 150():33-40. PubMed ID: 28011405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White blood cell count adds prognostic information to the thrombolysis in myocardial infarction risk index in patients following primary percutaneous coronary intervention (ANIN Myocardial Infarction Registry).
    Kruk M; Karcz M; Przyłuski J; Bekta P; Kepka C; Kalińczuk Ł; Pregowski J; Kaczmarska E; Demkow M; Chmielak Z; Witkowski A; Ruzyłło W
    Int J Cardiol; 2007 Apr; 116(3):376-82. PubMed ID: 16884793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of catheter-directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter-directed thrombolysis.
    Patel N; Patel NJ; Agnihotri K; Panaich SS; Thakkar B; Patel A; Savani C; Patel N; Arora S; Deshmukh A; Bhatt P; Alfonso C; Cohen M; Tafur A; Elder M; Mohamed T; Attaran R; Schreiber T; Grines C; Badheka AO
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1219-27. PubMed ID: 26308961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Submassive pulmonary embolism.
    Busse LW; Vourlekis JS
    Crit Care Clin; 2014 Jul; 30(3):447-73. PubMed ID: 24996605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the CHADS2 score for prognostic stratification of patients with acute myocardial infarction.
    Huang SS; Chen YH; Chan WL; Huang PH; Chen JW; Lin SJ
    Am J Cardiol; 2014 Nov; 114(9):1309-14. PubMed ID: 25205632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombolysis in pulmonary embolism with high mortality risk: Experience of a cardiology department in sub-Saharan Africa].
    Pessinaba S; Atti YDM; Baragou S; Yayehd K; Pio M; Afassinou YM; Kpelafia M; Kaziga WD; Simwetare MF; D'alméida R; Aloumon M; Agbétiafa M; Panchut Nsangou N; Damorou F
    Ann Cardiol Angeiol (Paris); 2019 Feb; 68(1):28-31. PubMed ID: 30290914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Lev EI; Kornowski R; Vaknin-Assa H; Porter A; Teplitsky I; Ben-Dor I; Brosh D; Fuchs S; Battler A; Assali A
    Am J Cardiol; 2008 Jul; 102(1):6-11. PubMed ID: 18572028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.